ArticleVaccines2025

Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age.

Tosin Omole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.